Welcome to our dedicated page for ICON PLC SEC filings (Ticker: ICLR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
ICON plc filings document current-report disclosures for a foreign private issuer in the clinical research organization sector. Form 6-K reports furnish press releases and exhibits on operating results, financial guidance, earnings-call scheduling, conference presentations, shareholder voting matters, governance updates, and clinical or regulatory disclosures.
The filings also record accounting-practices and internal-control matters, including revenue-recognition disclosures, as well as XBRL financial information covering operating results, equity accounts and reporting-segment data. These documents frame ICON’s public-company reporting around clinical development services, capital structure, governance and risk-related material events.
ICON PLC director Linda Grais reported equity transactions involving ordinary shares and restricted share units. On August 10, 2026, 1,732 restricted share units vested and were converted into 1,732 ordinary shares. She also received a new award of 1,324 restricted share units, scheduled to vest on May 22, 2027. On August 11, 2026, she sold 841 ordinary shares in multiple open-market transactions at weighted average prices between $162.08 and $166.1599 to cover tax withholding obligations through a non-discretionary “sell to cover” arrangement.
ICON plc director Dr. John Climax reported several equity transactions in August 2026. On August 10, 1,732 restricted share units vested and converted into 1,732 ordinary shares, and he received a new grant of 1,324 restricted share units. On August 11, he sold 841 ordinary shares in multiple transactions at weighted-average prices within stated ranges between $162.08 and $166.1599. A footnote states these sales were executed solely to cover tax withholding obligations via a “sell to cover” transaction, and are not discretionary trades. Each restricted share unit converts into one ordinary share, with a nominal conversion price equal to the shares’ EUR 0.06 par value deducted from his pay on vesting.
ICON plc Chief Financial Officer Nigel Bernard John Clerkin reported multiple equity transactions. On August 10, 2026 he exercised 4,293 restricted share units into ordinary shares and received grants of 14,164 new restricted share units and 4,793 stock options with a $166.05 exercise price expiring in 2034. Each restricted share unit converts into one ordinary share at a nominal EUR 0.06 per-share amount deducted from pay. On August 11, 2026 he sold 2,267 ordinary shares in open-market transactions solely to cover tax withholding obligations under a "sell to cover" arrangement, which the company states was not a discretionary trade.
ICON PLC director Kevin Francis Egan received an equity award. He was granted 1,324 Restricted Share Units, each representing a contingent right to receive one ordinary share upon vesting. The units were granted on August 10, 2026 and are scheduled to vest on May 22, 2027. A nominal conversion price equal to the ordinary shares’ par value of EUR 0.06 per share will be automatically deducted from his pay at vesting. Following this grant, he directly holds 1,324 restricted share units.
A shareholder of ICLR filed a notice to sell up to 841 shares of the company’s common stock through Morgan Stanley Smith Barney LLC. The proposed sale, with an aggregate market value of $138,169.82, is listed for August 11, 2026 on NASDAQ. The shares were acquired on August 10, 2026 as restricted stock vesting under a registered plan in connection with services rendered.
ICLR has a shareholder giving notice of a proposed sale of common stock. The notice covers 841 shares to be sold through Morgan Stanley Smith Barney LLC on or after 08/11/2026 on NASDAQ, with an indicated aggregate market value of $138,169.82. These shares were acquired as restricted stock vesting under a registered plan on 08/10/2026 in exchange for services rendered.
ICON plc (ICLR) has a Form 144 notice for a planned sale of common stock. A holder intends to sell up to 841 shares of common stock through Morgan Stanley Smith Barney LLC Executive Financial Services on the NASDAQ on 08/11/2026, with an indicated aggregate value of $138,169.82.
The 841 shares were acquired on 08/10/2026 through restricted stock vesting under a registered plan as compensation for services rendered, and are reported as securities acquired during the past three months.
ICLR reported a planned sale of 841 shares of its common stock through Morgan Stanley Smith Barney LLC Executive Financial Services on the NASDAQ, expected on 08/11/2026. The shares were acquired on 08/10/2026 via restricted stock vesting under a registered plan as compensation for services rendered.
ICON plc (ICLR) filed a notice of proposed sale of common stock under Rule 144. The filing lists 841 shares of common stock held at Morgan Stanley Smith Barney LLC Executive Financial Services, with an aggregate market value of $138,169.82, to be sold on August 11, 2026 on NASDAQ. The shares were acquired on August 10, 2026 through restricted stock vesting under a registered plan as compensation for services rendered.
A holder of ICON plc (ICLR) common stock filed a notice to sell 915 shares on the NASDAQ under Rule 144. The shares arise from restricted stock vesting on 08/10/2026 under a registered plan, with brokerage handled by Morgan Stanley Smith Barney LLC Executive Financial Services.